← Back to news
NewsCURRENT OPINION IN HEMATOLOGYThursday, January 29, 2026 · January 29, 2026

Navigating prognostic stratification and approach to TP53 -mutated myeloid neoplasms.

WHY IT MATTERS

Recent peer-reviewed research on Myelodysplastic syndrome that may be relevant for patients and caregivers.

TP53- mutated ( TP53 -MT) myeloid neoplasms (MN) represent one of the most challenging disease subsets due to their distinct pathobiology, frequent association with therapy-related disease, chemo-resistant phenotype, and dismal outcomes. The prognostic impact of TP53 -MT is not uniform and is influe...

Read on PubMed
Read the original at Current opinion in hematology
ResearchPubMedMyelodysplastic syndromeHumansTumor Suppressor Protein p53

Related conditions

Myelodysplastic syndrome

Related news

Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.